$RXMD. Rxmd is just warming up now. S-1 filed for possible up list to Nasdaq. Reverse merger news about to hit anytime taking the yearly revenues to 100Million. Low OS of 480M with 350 float. Operations expanded to COVID testing. This stock could hit a 1$ or more by March 15 annual release. 4 years of audited financials. But now and don’t miss the run